PharmGen Science Inc Net Asset Quality Index
PharmGen Science Inc net asset quality index. PharmGen Science Inc (004720) has a Net Asset Quality Index of 74.7% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ₩331.46 Billion minus total liabilities of ₩83.70 Billion yields net assets of ₩247.76 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check earnings quality score of PharmGen Science Inc to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of PharmGen Science Inc (2004–2024)
Net asset quality index of PharmGen Science Inc from 2004 to 2024. This chart shows how PharmGen Science Inc's Net Asset Quality Index has evolved across 17 annual periods from 2004 to 2024. As of September 2025, the index stands at 74.7%, representing net assets of ₩247.76 Billion against total assets of ₩331.46 Billion KRW. See PharmGen Science Inc shareholders equity for net asset value and shareholders' equity analysis.
PharmGen Science Inc Net Asset Quality Index by Year (2004–2024)
PharmGen Science Inc net asset quality index by year from 2004 to 2024. The table below presents the year-by-year Net Asset Quality Index for PharmGen Science Inc from 2004 to 2024, covering 17 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see PharmGen Science Inc (004720) total market value.
| Year | Quality Index | Net Assets (KRW) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 68.6% | ₩249.43 Billion | ₩363.45 Billion | ₩114.02 Billion | ▲ +0.7 pp |
| 2023 | 67.9% | ₩228.21 Billion | ₩335.92 Billion | ₩107.71 Billion | ▲ +2.7 pp |
| 2022 | 65.3% | ₩207.12 Billion | ₩317.39 Billion | ₩110.28 Billion | ▲ +7.6 pp |
| 2021 | 57.6% | ₩126.93 Billion | ₩220.32 Billion | ₩93.39 Billion | ▼ -4.0 pp |
| 2020 | 61.7% | ₩83.57 Billion | ₩135.54 Billion | ₩51.97 Billion | ▲ +5.4 pp |
| 2019 | 56.2% | ₩56.25 Billion | ₩100.03 Billion | ₩43.79 Billion | ▼ -1.7 pp |
| 2018 | 57.9% | ₩56.85 Billion | ₩98.19 Billion | ₩41.35 Billion | ▼ -16.7 pp |
| 2017 | 74.6% | ₩51.05 Billion | ₩68.48 Billion | ₩17.43 Billion | ▲ +17.9 pp |
| 2016 | 56.6% | ₩36.41 Billion | ₩64.30 Billion | ₩27.89 Billion | ▼ -5.1 pp |
| 2015 | 61.7% | ₩28.66 Billion | ₩46.45 Billion | ₩17.79 Billion | ▲ +13.9 pp |
| 2014 | 47.8% | ₩20.12 Billion | ₩42.04 Billion | ₩21.93 Billion | ▼ -12.8 pp |
| 2013 | 60.6% | ₩23.83 Billion | ₩39.33 Billion | ₩15.49 Billion | ▼ -0.2 pp |
| 2012 | 60.8% | ₩25.90 Billion | ₩42.61 Billion | ₩16.71 Billion | ▲ +17.1 pp |
| 2011 | 43.6% | ₩18.69 Billion | ₩42.82 Billion | ₩24.13 Billion | ▼ -6.1 pp |
| 2005 | 49.8% | ₩33.07 Billion | ₩66.47 Billion | ₩33.40 Billion | ▼ -0.6 pp |
| 2004 | 50.3% | ₩24.91 Billion | ₩49.49 Billion | ₩24.58 Billion | ▼ -1.2 pp |
| 2004 | 51.6% | ₩25.73 Billion | ₩49.90 Billion | ₩24.17 Billion | — |